Miller, Kurt
Steger, Günther G.
Niepel, Daniela
Lüftner, Diana
Funding for this research was provided by:
Amgen (Europe) GmbH
Article History
Received: 31 October 2017
Revised: 20 February 2018
Accepted: 19 March 2018
First Online: 9 July 2018
Compliance with ethical standards
:
: Kurt Miller has received consultancy fees from Amgen, Astellas, Bayer, Bristol-Myers Squibb, Ferring, Janssen, Medivation, Merck, Merck Sharp & Dohme, Pfizer and Roche, and consultancy fees, and grants from Novartis. Günther Steger has received honoraria and travel support from, and has attended advisory boards for, Amgen. Daniela Niepel is an employee of Amgen and holds stock. Diana Lüftner is member of advisory boards and speaker bureaus for Amgen.